Related Experiment Videos
Congenital coagulation protein deficiencies in the perinatal period
1Department of Pediatrics, Brown University, Providence, RI.
Insights
Congenital bleeding disorders, like hemophilia A and B, are rare but serious in newborns. Early detection and management are crucial for preventing severe complications in infants.
Area of Science:
- Pediatric Hematology
- Neonatal Medicine
- Coagulation Disorders
Background:
- Congenital deficiencies of clotting proteins, including hemophilia A and B, are less common but can be as severe as acquired bleeding disorders in neonates.
- Delayed diagnosis is frequent due to lack of family history or asymptomatic parents, complicating early identification.
- Physiologically low factor levels in newborns can hinder interpretation of standard hemostasis tests.
Purpose of the Study:
- To highlight the importance of recognizing congenital clotting protein deficiencies in neonates.
- To provide guidance on diagnosing these disorders based on clinical presentation and age-adjusted laboratory values.
- To emphasize timely intervention strategies for improved neonatal outcomes.
Main Methods:
- Review of clinical presentations suggestive of congenital factor deficiencies.
- Emphasis on the utility of age-adjusted coagulation factor level interpretation.
- Discussion of diagnostic indicators such as CNS bleeding and umbilical stump bleeding.
Main Results:
- Serious CNS bleeding in healthy infants warrants suspicion of congenital clotting disorders.
- Prolonged umbilical stump bleeding suggests Factor XIII or other rare factor deficiencies.
- Early detection of CNS hemorrhage via bedside ultrasound and prompt treatment with fresh frozen plasma can prevent severe sequelae.
Conclusions:
- Congenital factor deficiencies require high clinical suspicion, especially with specific bleeding patterns in neonates.
- Age-adjusted laboratory interpretation is essential for accurate diagnosis.
- Multimodal approaches including advanced imaging and rapid treatment are vital for managing these critical conditions.
Abstract:
Less common than acquired bleeding disorders in the perinatal period, congenital deficiencies of the clotting proteins, particularly the hemophilias A and B, can be just as devastating. Detection of these disorders may be delayed because a suspect family history is lacking in up to one third of the cases of hemophilia, and parents are usually asymptomatic in the other congenital factor deficiencies. Physiologically low levels of the liver-dependent and contact factors can make the interpretation of the common hemostasis screens difficult. Hence, the use of age-adjusted tables such as those presented here is essential. Congenital deficiencies of clotting proteins should be suspected when serious CNS bleeding occurs in an otherwise healthy baby generally after a day or two. Factor XIII or other less common factor deficiencies should be sought when there is prolonged bleeding from the umbilical stump. Bleeding after circumcision is a rare early indicator nowadays with better techniques. The availability of bedside ultrasound to detect CNS hemorrhage early and of fresh frozen plasma for treatment preceding the results of specific factor assays should prevent serious sequelae. Elective cesarean section is currently recommended when an unborn infant is known to have hemophilia.